Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Medtronic plc    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/11/2020 09/14/2020 09/15/2020 09/16/2020 09/17/2020 Date
104.77(c) 106.97(c) 107.57(c) 107.49(c) 107.81(c) Last
2 836 657 4 393 610 3 293 590 3 723 898 3 541 857 Volume
-0.01% +2.10% +0.56% -0.07% +0.30% Change
More quotes
Financials (USD)
Sales 2021 29 238 M - -
Net income 2021 3 963 M - -
Net Debt 2021 19 821 M - -
P/E ratio 2021 36,7x
Yield 2021 2,09%
Sales 2022 32 174 M - -
Net income 2022 5 964 M - -
Net Debt 2022 15 704 M - -
P/E ratio 2022 24,2x
Yield 2022 2,20%
Capitalization 145 B 145 B -
EV / Sales 2021 5,63x
EV / Sales 2022 4,99x
Nbr of Employees 90 000
Free-Float 99,9%
More Financials
Company
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.9%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - vascular diseases and cardiac surgery (18.4%): coronary stents, endoprostheses for aortal pathologies, distal protection... 
More about the company
Notations Surperformance© of Medtronic plc
Trading Rating : Investor Rating :
More Ratings
All news about MEDTRONIC PLC
09/17MEDTRONIC : TYRX Absorbable Antibacterial Envelope Is Cost Effective for Patient..
AQ
09/17SANUWAVE CEO To Present At HC Wainwright 22nd Annual Global Investment Confer..
AQ
09/15MEDTRONIC : Canada Recognized as One of the Best Workplaces™ in Healthcare..
AQ
09/14MEDTRONIC : CEO Geoff Martha to Speak at Morgan Stanley Global Healthcare Confer..
AQ
09/11MEDTRONIC : CEO Geoff Martha to Speak at Morgan Stanley Global Healthcare Confer..
AQ
09/11MEDTRONIC : CEO Geoff Martha to Speak at Morgan Stanley Global Healthcare Confer..
PR
09/11MEDTRONIC : Study Finds Opioid-Induced Respiratory Depression in the Hospital Mo..
AQ
09/10MEDTRONIC : Receives Breakthrough Device Designation from FDA, Begins Early Feas..
AQ
09/10MEDTRONIC : Study Finds Opioid-Induced Respiratory Depression in the Hospital Mo..
AQ
09/10MEDTRONIC : Study Finds Opioid-Induced Respiratory Depression in the Hospital Mo..
PR
09/10MEDTRONIC : Receives Breakthrough Device Designation from FDA, Begins Early Feas..
AQ
09/10SANUWAVE CEO To Present At "The Global Chinese Financial Forum" Thursday, Sep..
AQ
09/09MEDTRONIC : Begins Early Feasibility Study for Intrepid Transcatheter Valve Syst..
DJ
09/09MEDTRONIC : Receives Breakthrough Device Designation from FDA, Begins Early Feas..
AQ
09/09MEDTRONIC : Receives Breakthrough Device Designation from FDA, Begins Early Feas..
PR
More news
News in other languages on MEDTRONIC PLC
08/25Le S&P-500 et le Nasdaq à des niveaux record, le Dow Jones en baisse
08/25WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
08/25MEDTRONIC : BPA ajusté divisé par deux au 1er trimestre
08/25EN DIRECT DES MARCHES : LVMH, EssilorLuxottica, Ipsen, MND, Salesforce, Wirec..
08/25Vaccin, Chine, Election, le décor est planté
More news
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 116,72 $
Last Close Price 107,81 $
Spread / Highest target 20,6%
Spread / Average Target 8,26%
Spread / Lowest Target -16,5%
EPS Revisions
Managers
NameTitle
Geoffrey Straub Martha Chief Executive Officer & Director
Omar S. Ishrak Executive Chairman
Mark Ploof Senior VP-Global Operations & Business Services
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Richard E. Kuntz Senior VP, Chief Scientific & Clinical Officer
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC-4.97%144 920
ABBOTT LABORATORIES22.80%188 845
BECTON, DICKINSON AND COMPANY-16.24%66 032
BAXTER INTERNATIONAL INC.-1.55%41 673
HOYA CORPORATION8.66%40 612
DEXCOM, INC.76.56%36 977